Of note, unlike in CAPItello-291, the results reported here are not specific to patients with HR-positive/HER2-negative advanced breast cancer, as our cohort included patients with various breast cancer subtypes, regardless of HR/HER2 status. The gene discussed is ERBB2; the disease is breast carcinoma.